The Beauty Health Company (SKIN)
The Beauty Health Company (SKIN) Q4 2025 Earnings Call Transcript
The Beauty Health Company (SKIN) Q4 2025 Earnings Call Transcript
Beauty Health (SKIN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Beauty Health (SKIN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The Beauty Health Company (SKIN) Reports Q4 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.08 per share a year ago.
Unveiling Beauty Health (SKIN) Q4 Outlook: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Beauty Health (SKIN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Unlocking Beauty Health (SKIN) International Revenues: Trends, Surprises, and Prospects
Explore how Beauty Health's (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q3 Earnings
Although the revenue and EPS for Beauty Health (SKIN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.15 per share a year ago.
Fast-paced Momentum Stock Beauty Health (SKIN) Is Still Trading at a Bargain
Beauty Health (SKIN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
International Markets and Beauty Health (SKIN): A Deep Dive for Investors
Examine the evolution of Beauty Health's (SKIN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
The Beauty Health Company (SKIN) Q2 2025 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Marla Malcolm Beck - President, CEO & Director Michael P. Monahan - Chief Financial Officer Conference Call Participants Alec Edward Legg - Canaccord Genuity Corp., Research Division Bruce David Jackson - The Benchmark Company, LLC, Research Division Joseph Paul Federico - Stifel, Nicolaus & Company, Incorporated, Research Division K.
Beauty Health (SKIN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Beauty Health (SKIN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Beauty Health Company (SKIN) Surpasses Q2 Earnings and Revenue Estimates
The Beauty Health Company (SKIN) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to a loss of $0.1 per share a year ago.
